These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 21813309)
1. Oxidative stress in phenylketonuric patients. Vargas CR; Wajner M; Sitta A Mol Genet Metab; 2011; 104 Suppl():S97-9. PubMed ID: 21813309 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in phenylketonuria: what is the evidence? Ribas GS; Sitta A; Wajner M; Vargas CR Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352 [TBL] [Abstract][Full Text] [Related]
3. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Sitta A; Barschak AG; Deon M; Barden AT; Biancini GB; Vargas PR; de Souza CF; Netto C; Wajner M; Vargas CR Int J Dev Neurosci; 2009 May; 27(3):243-7. PubMed ID: 19429389 [TBL] [Abstract][Full Text] [Related]
4. Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients. Kumru B; Kaplan DS; Oztürk Hismi B; Celik H Cell Mol Neurobiol; 2018 Jul; 38(5):1033-1038. PubMed ID: 29285660 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system]. Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314 [TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of antioxidant status in phenylketonuric patients. Artuch R; Colomé C; Sierra C; Brandi N; Lambruschini N; Campistol J; Ugarte D; Vilaseca MA Clin Biochem; 2004 Mar; 37(3):198-203. PubMed ID: 14972641 [TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498 [TBL] [Abstract][Full Text] [Related]
8. 2-Methylbutyrylglycine induces lipid oxidative damage and decreases the antioxidant defenses in rat brain. Knebel LA; Zanatta Â; Tonin AM; Grings M; Alvorcem Lde M; Wajner M; Leipnitz G Brain Res; 2012 Oct; 1478():74-82. PubMed ID: 22967964 [TBL] [Abstract][Full Text] [Related]
9. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients. Kumru B; Ozturk Hismi B; Kaplan DS; Celik H J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252 [TBL] [Abstract][Full Text] [Related]
10. Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients. Rausell D; García-Blanco A; Correcher P; Vitoria I; Vento M; Cháfer-Pericás C Pediatr Res; 2019 Jan; 85(2):242-250. PubMed ID: 30333522 [TBL] [Abstract][Full Text] [Related]
11. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675 [TBL] [Abstract][Full Text] [Related]
13. Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain. Schuck PF; Ferreira GC; Moura AP; Busanello EN; Tonin AM; Dutra-Filho CS; Wajner M Neurochem Int; 2009 Jul; 54(8):519-25. PubMed ID: 19428797 [TBL] [Abstract][Full Text] [Related]
14. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of biomarkers of oxidative stress and antioxidant capacity in the cord blood of preterm low birth weight neonates. Negi R; Pande D; Kumar A; Khanna RS; Khanna HD J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1338-41. PubMed ID: 22046974 [TBL] [Abstract][Full Text] [Related]
16. Selenium inadequacy is not associated with oxidative stress in child and adolescent acute lymphocytic leukemia survivors. Almondes KG; de Oliveira TF; Siviero-Miachon AA; Lee ML; Rondó PH; Loureiro AP; Spinola-Castro AM; Cozzolino SM Nutrition; 2014 May; 30(5):563-8. PubMed ID: 24698347 [TBL] [Abstract][Full Text] [Related]
17. The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Schulpis KH; Papastamataki M; Stamou H; Papassotiriou I; Margeli A Acta Paediatr; 2010 Oct; 99(10):1565-70. PubMed ID: 20491710 [TBL] [Abstract][Full Text] [Related]
18. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients. Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260 [TBL] [Abstract][Full Text] [Related]
19. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Mancuso M; Bonanni E; LoGerfo A; Orsucci D; Maestri M; Chico L; DiCoscio E; Fabbrini M; Siciliano G; Murri L Sleep Med; 2012 Jun; 13(6):632-6. PubMed ID: 22534161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]